Skip to content
thestock.space

Rossari Biotech (ROSSARI) had a P/E of 15.5× on 6 Nov 2026, below the industry P/E of 22.1×, and the shares are 34% below their 52-week high. Sales and net profit grew 13% and 12% a year over 3 years, with ROCE of 15% and ROE of 11%. Debt is 0.28× equity, and its dividend yield is 0.1%. It is a small-cap company with a market cap of ₹2,367 Cr, ranked 54th of 204 Specialty Chemicals companies by market cap; the shares fell 35% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹419.15
Day high
₹430.00
Day low
₹415.00
Prev. close
₹421.40
Volume
39.8K

Health check

2 good · 1 fair · 3 to check
  • ReturnsBehind

    −35.2% over a year, better than 0 of 7 peers.

  • Price tagCheaper

    P/E 15.5 vs industry 22.1.

  • GrowthSteady

    Sales +13.1%, profit +11.6% a year over 3 years.

  • ProfitabilityWeak

    ROCE 15.4% vs peer median 24.4%.

  • Balance sheetSolid

    Debt 0.28× equity, interest covered 8.1×.

  • Red flags1 to check

    34% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹2,367 Cr, #54 of 204 in its industry by size.

Defensive

Beta 0.56 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹2,661 Cr · profit ₹153 Cr
Market cap
₹2,367 Cr
Small cap
P/E
15.5
Industry 22.1
Price to book
1.68
Peers 13.33
Dividend yield
0.12%
ROE
11.5%
Peers 23.0%
ROCE
15.4%
Peers 24.4%
Debt to equity
0.28
Debt ₹388 Cr
EPS (TTM)
₹27.56
Face value ₹2
OPM (TTM)
11.8%
Net margin 5.7%
Sales growth
+19.0%
Latest quarter vs a year ago
Profit growth
+5.6%
Latest quarter vs a year ago
Price to sales
0.89
EV/EBITDA 9.1

Strengths and risks

Strengths

  • Quarterly sales up 19.0% on a year ago.
  • P/E of 15.5 against an industry P/E of 22.1.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • 34% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Rossari Biotech

Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers home, personal care, and performance chemicals products, such as soaps and detergents; oil and gas division; inks; paints and coatings; ceramics and tiles; pulp and paper; cement; water treatment; performance additives; cleaning, hygiene, and disinfection; surfactants; and textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk,…

Headquarters
Mumbai
Employees
585
Sector
Basic Materials
ISIN
INE02A801020
Website
rossari.com

Price range

52 weeks

₹375.00₹652.25

Today

₹415.00₹430.00
Avg volume (3M)
77.1K
1-year return
minus 35.2%
From 52-week high
minus 34.5%

Peers · Specialty Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.535.024.4%18.9%0.211.1%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.464.129.5%27.8%0.2212.4%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.044.428.5%23.5%0.037.4%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.464.216.3%31.5%0.23–plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.429.420.6%15.3%0.154.2%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.944.09.6%24.1%0.26−4.5%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.964.127.7%39.4%0.0129.4%plus 105.6%
ROSSARIRossari Biotech427.30plus 1.40%2,36715.59.6–8.2%0.2813.1%minus 35.2%
Median of 7 peers–0.48%58,49670.944.424.4%24.1%0.215.8%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Dec 25Mar 26Jun 26Sep 26
544582685697698
476513608617611
67.968.977.380.687
12.5%11.8%11.3%11.6%12.5%
1.70.919.63.61.1
5.77.79.1118.7
17.719.623.525.630.1
46.142.564.247.749.3
27.1%22.9%28.4%26.4%21.0%
33.632.84635.138.9
6.065.918.296.337.02

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+13.1%
Profit CAGR 3Y
+11.6%
EPS CAGR 3Y
+11.6%
ROE
11.5%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1,6511,8252,0712,390
–+10.5%+13.5%+15.4%
1,4371,5821,8172,121
215243255269
13.0%13.3%12.3%11.3%
13.99.813.921
22.319.417.828.5
62.960.467.179.1
14.41.620.1
144178185203
25.6%26.4%26.4%26.3%
107131136149
–+21.8%+4.4%+9.4%
19.3823.6224.6326.93

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
111111.111.1
9041,0371,1741,322
73.9119218436
378406493520
1,3681,5721,8962,289
334425556756
20.8110202195
0.20.20.20.7
14869.5105113
8649671,0331,224
1,3681,5721,8962,289

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
15243.313765.1
−181−103−184−219
60.916.264.9186
31.5−43.818.631.9
−32.9−131−159−265
119−88−21.1−200
−2.8−2.8−2.8−2.8

Shareholding pattern

Source: NSE filings
68.1%
promoters
  • Promoters68.14%
  • Public31.86%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202668.14%31.86%0.00
30 Jun 202668.14%31.86%minus 0.01
31 Mar 202668.15%31.85%minus 0.01
31 Dec 202568.16%31.84%minus 0.01
30 Sep 202568.17%31.83%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you